Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N′-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N′-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamides

Publication | Open Access

DOI Full Paper Access

Citations

References

2001

Year

Marc Gerspacher, Luigi La Vecchia, Robert Mah, Andreas von Sprecher, Gary P. Anderson, N. Subramanian, Kathleen Hauser, Heinrich Bammerlin, Sabine Kimmel, Viviane Pawelzik,

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyMedicinal ChemistryMedicinePharmacological AgentNeuropharmacologyPeptide SciencePharmacotherapyDual Neurokinin Nk1/nk2PharmacologyPharmaceutical Chemistry